Gastric mucosal lesions
Conditions
Interventions
Group A:first magnetron capsule endoscopy then electronic gastroscopy
Group B:first electronic gastroscopy thenmagnetron capsule endoscopy
Sponsors
Southern Medical University, Nanfang Hospital, Department of Gastroenterology
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. 18-70 years old, male or female; 2. has a clear stomach lesions (atrophic gastritis, gastric ulcer, gastric polyps, gastric cancer, gastric stromal tumors, etc.),have received medical treatment or therapy under endoscopy (APC, EMR, ESD, ligation, etc.), need regular follow-up, and these lesions need to have gastroscopy report; 3. the patient agreed to participate in this experiment, and voluntary signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. this follow-up required therapeutic endoscopy (clearly have the stomach, esophageal mucosal lesions within the required endoscopic treatment); 2. known or suspected gastrointestinal obstruction, strictures and fistula, or suffering from inflammatory bowel disease (such as Crohn's disease and ulcerative colitis), gastrointestinal dysfunction, patients with acute gastrointestinal during the current test; 3. no surgical conditions or refuse to accept any abdominal surgery (once the residence of the capsule will not be removed by surgery); 4. heart pacemakers or other electronic equipment by magnetic interference implant; 5. can not tolerate ordinary endoscopy, the patient required painless gastroscopy; 6. the patient who has been involved in this study; 7. swallowing disorders or pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Past lesion detection rate; | — |
Countries
China
Contacts
Public ContactSide Liu
Outcome results
None listed